Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00466
|
|||||
Drug Name |
Ivacaftor
|
|||||
Synonyms |
Kalydeco (TN)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Cystic fibrosis [ICD11: CA25] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C24H28N2O3
|
|||||
Canonical SMILES |
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
|
|||||
InChI |
InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
|
|||||
InChIKey |
PURKAOJPTOLRMP-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 873054-44-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 392.5 | Topological Polar Surface Area | 78.4 | ||
Heavy Atom Count | 29 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
5.6
|
|||||
PubChem CID | ||||||
PubChem SID |
104253162
, 118855344
, 123051083
, 124757031
, 124950685
, 125163835
, 125299328
, 125434146
, 126661313
, 126731535
, 131480767
, 134964550
, 135264255
, 135626653
, 135653729
, 135692075
, 135727452
, 136367331
, 136367911
, 136926964
, 137031731
, 137626819
, 137626820
, 144116089
, 152134181
, 152258419
, 160645564
, 160647255
, 160874442
, 162011579
, 162037465
, 162202744
, 163894050
, 164042021
, 172919866
, 175266660
, 175427103
, 178101159
, 184819711
, 187072829
, 198993065
, 223381530
, 223471420
, 223683825
, 223705162
, 224174132
, 226685555
, 24902571
, 28764112
, 40723266
|
|||||
ChEBI ID |
ChEBI:66901
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Ivacaftor was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Investigation of the effects of the CFTR potentiator ivacaftor on human P-glycoprotein (ABCB1). Sci Rep. 2017 Dec 13;7(1):17481. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.